Khalid Tinasti, Ann Fordham y David Bewley-Taylor se preguntan cómo influirá el nuevo liderazgo de la OMS y el PNUD sobre las posiciones de estos organismos con respecto a las políticas de drogas y la reducción de daños. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas. 


The UN General Assembly Special Session on drugs held in April 2016 has been organized by the international drug control entities, but has confirmed the inclusion of other UN agencies in the global debates on drugs. Out of these, WHO and UNDP have played a major role in linking drug policy with the priorities of protecting human rights and promoting sustainable development. In May 2017, the leadership of both agencies will change. This letter reviews the aspiring leaders of these agencies’ positions on drug policies through existing literature, providing more clarity on their past or current commitment to the issue of drug policy and harm reduction stakeholders.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.